New Clinical Data Highlighting Safety and Efficacy of EndoBarrier® Therapy Presented at the 19th World Congress of International Federation for the Surgery of Obesity and Metabolic Disorders

Data Further Demonstrate the Utility of EndoBarrier Therapy in the Treatment of Patients with Type 2 Diabetes and Obesity MONTREAL, Canada, LEXINGTON, United States and SYDNEY, Australia – 29 August 2014 – GI Dynamics, Inc. (ASX: GID), a medical device company...